Gen-Probe's Q4 Revenues Slide 2 Percent

During the quarter, revenues were negatively affected by decreased sales of its Tigris system to Novartis and tough year-ago comparisons with the H1N1 pandemic.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories